Publication:
Proposal for a preventive protocol for medication-related osteonecrosis of the jaw.

dc.contributor.authorRomero-Ruiz, M-M
dc.contributor.authorRomero-Serrano, M
dc.contributor.authorSerrano-González, A
dc.contributor.authorSerrera-Figallo, M-Á
dc.contributor.authorGutiérrez-Pérez, J-L
dc.contributor.authorTorres-Lagares, D
dc.date.accessioned2023-02-09T09:43:12Z
dc.date.available2023-02-09T09:43:12Z
dc.date.issued2021-05-01
dc.description.abstractMedication-related osteonecrosis of the jaw (MRONJ) is a severe adverse reaction experienced by some patients exposed to certain drugs (antiresorptives such as bisphosphonates or denosumab, and antiangiogenic drugs). From a review of the literature it appears that there is no uniform criterion when selecting preventive measures; these vary according to author. Likewise, the measures recommended are usually general, so that in few cases they result in specific actions to be applied depending on the different variables involved such as the type of drug used, the duration of its application, the underlying pathology, the presence or absence of risk factors, etc. The aim of this study has been to design a preventive protocol which can be easily applied in any clinic or by any dental care service. We undertook an exhaustive literature review to find any articles related to the topic of study, namely, preventive measures for medication-related osteonecrosis of the jaw, on the one hand generically and on the other focusing on dental implant treatment. The most part the criteria of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. From 3946 items, we selected a total of 21 items. From the analysis of the selected articles, several protocols have been developed that are easy to apply in a dental clinic.: Protocol 1. Before starting treatment with antiresorptives (Patients who are going to be treated for osteoporosis / Patients who are going to be treated for cancer). Protocol 2. Once treatment is initiated with antiresorptives (Patients being treated for osteoporosis / Patients being treated for cancer). The application of these protocols requires an interdisciplinary team which can handle the various treatments and apply the measures contained in them. Along with a team of well-educated and trained dentists, it is equally important to maintain contact with the medical team involved in the treatment of the underlying pathology, especially rheumatologists, oncologists, internists and gynaecologists. All the above requires a great staff learning and organization effort, continuous training and coordination of the whole team involved in the preventive management of these patients.
dc.identifier.doi10.4317/medoral.24197
dc.identifier.essn1698-6946
dc.identifier.pmcPMC8141321
dc.identifier.pmid33037798
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141321/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.4317/medoral.24197
dc.identifier.urihttp://hdl.handle.net/10668/16390
dc.issue.number3
dc.journal.titleMedicina oral, patologia oral y cirugia bucal
dc.journal.titleabbreviationMed Oral Patol Oral Cir Bucal
dc.language.isoen
dc.organizationHospital Universitario Puerta del Mar
dc.page.numbere314-e326
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rights.accessRightsopen access
dc.subject.meshBisphosphonate-Associated Osteonecrosis of the Jaw
dc.subject.meshBone Density Conservation Agents
dc.subject.meshDiphosphonates
dc.subject.meshHumans
dc.subject.meshOsteonecrosis
dc.subject.meshOsteoporosis
dc.titleProposal for a preventive protocol for medication-related osteonecrosis of the jaw.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number26
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8141321.pdf
Size:
5.77 MB
Format:
Adobe Portable Document Format